Pre-Open Stock Movers 11/12: (ANGI) (NTES) (GALE) Higher; (DSCI) (DGLY) (FRPT) Lower (more...)
Tweet Send to a Friend
Derma Sciences (NASDAQ: DSCI) 29.4% LOWER; announces the termination of its Phase 3 clinical trials with aclerastide (DSC127) for diabetic ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


